This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on ISI (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Immunotherapy holds promise as a simple method for treating common warts.^1-4 Injection with one sensitizing agent, Candida antigen, has been adopted by some physicians without the support of any published studies. Our goals were to evaluate (1) the safety of Candida antigen injections for the treatment of common warts, (2) patient satisfaction with the treatment, and (3) response rates.

Review of Cases

We performed a retrospective chart review of 149 consecutive adult and pediatric patients at a referral procedures practice who were treated with intralesional and intradermal injection of a 1:1 mixture of Candida antigen (Candin; Allermed Laboratories, San Diego, Calif) solution and 1% lidocaine. Most patients had long-standing warts that had not responded to home treatment or treatment by other physicians. The mixture (0.1 mL) was injected into each of multiple warts (genital and facial warts excluded) up to 1.0 mL total. Injections were repeated every 4 weeks for a total of . . . [Full Text of this Article]

Comment

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intralesional Immunotherapy of Warts With Mumps, Candida, and Trichophyton Skin Test Antigens: A Single-blinded, Randomized, and Controlled Trial
Horn et al.
Arch Dermatol 2005;141:589-594.
ABSTRACT | FULL TEXT  

Successful Treatment of Flat Warts Using Intralesional Candida Antigen
Ritter and Meffert
Arch Dermatol 2003;139:541-542.
FULL TEXT